Corporate news

Media contacts:

T: +44(0) 1895 826 654

T: +44(0) 1895 826 227

contact@norgine.com

Corporate news items are intended for business/trade media and for analysts/investors.

Norgine B.V. acquires SETOFILM^® (ondansetron oral dispersible film) in Europe, Australia and New Zealand From APR Applied Pharma Research S.A.
01 October 2020
Read media release
Norgine B.V. enters into an agreement to dispose of its rights to EMSELEX^® (darifenacin) in Europe to pharma&
01 October 2020
Read media release
Norgine B.V. completes important regulatory milestone for ANGUSTA^® (misoprostol) in Europe for oral induction of labour
17 August 2020
Read media release
Olympus acquires Arc Medical Design Limited from Norgine B.V.
07 August 2020
Read media release
Norgine B.V. enters into exclusive distribution agreement for the commercialisation of glyceryl trinitrate transdermal patch with Medfatop Ltd in Vietnam
30 July 2020
Read media release
Norgine receives RoSPA Gold Medal for health and safety sixth year in a row
28 July 2020
Read media release
AMAG Pharmaceuticals and Norgine B.V. enter into exclusive licensing agreement to commercialize ciraparantag in Europe, Australia and New Zealand
23 July 2020
Read media release
Norgine B.V. senior management changes: Christopher Bath appointed Chief Operating Officer
16 June 2020
Read media release
Norgine are here to support you, wherever we are. #Coronavirus #COVID19
31 March 2020
Read media release
From all of us at Norgine, we would like to say thank you! #Coronavirus #COVID19
30 March 2020
Read media release
Norgine B.V. acquires Azanta A/S, strengthening its position as a leading European specialist pharmaceutical company
24 March 2020
Read media release
Norgine B.V. enters into exclusive licence and distribution agreements for the commercialisation of PLENVU^® in a number of countries in Latin America, Southern Africa, Central and Eastern Europe
12 February 2020
Read media release

Access corporate news archive